Home / Recalls / Nephron Pharmaceuticals Corp. / Z-1373-2013

Z-1373-2013 Class I Terminated

Recalled by Nephron Pharmaceuticals Corp. — Orlando, FL

Recall Details

Product Type
Devices
Report Date
June 5, 2013
Initiation Date
April 30, 2013
Termination Date
June 28, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
750 Medications Cups

Product Description

EZ Breathe Medication Cup. For the delivery of liquid medications for respiratory usage.

Reason for Recall

Possible dislodgement of the "Plate A", if this instance occurs, it presents a potential choking hazard.

Distribution Pattern

Worldwide Distribution-USA (nationwide) including DC and Puerto Rico and the states of AL, AZ, CA, CO, CT, FL, IL, IN, IO, GA, KS, KY, LA, MD, MN, MS, MO, NK, NV, NJ, NM, NY, OH, OK, OR, PA, RI, SC, TN , TX, VT, VA, WA, and WV, and the countries of Guatemala, Poland, Panama, and United Kingdom.

Code Information

Lots #120902, Lot # 120903 and Lot # 120904

Other recalls by Nephron Pharmaceuticals Corp.

  • Z-2053-2016 Class II — Sodium Chloride Inhalation Solution, USP 3%, 60 x 4 mL Sterile Unit-Dose Vials p (November 16, 2015)
  • Z-2054-2016 Class II — Sodium Chloride Inhalation Solution, USP 7%, 60 x 4 mL Sterile Unit-Dose Vials, (November 16, 2015)
  • D-0389-2016 Class II — Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator Refills (Racepin (August 21, 2015)
  • D-0010-2016 Class II — Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution, packa (August 21, 2015)
  • D-0388-2016 Class II — Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator, Starter Kit (Rac (August 21, 2015)
  • D-66462-001 Class II — Albuterol Sulfate Inhalation Solution, 0.083% 2.5 mg/3 mL for Oral Inhalation O (October 2, 2013)
  • Z-1371-2013 Class I — EZ Breathe Atomizer Model # EZ-100. For the delivery of liquid medications f (April 30, 2013)
  • Z-1372-2013 Class I — AsthmaNefrin Starter Kit contains ten (10) AsthmaNefrin vials and one (1) EZ Bre (April 30, 2013)
  • D-1446-2012 Class II — Albuterol Sulfate Inhalation Solution, 0.083%, 2.5 mg/3 mL Sterile Unit-Dose Via (June 22, 2011)